Grey Fox Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-202
Closed -$19.6K 152
2023
Q1
$19.6K Sell
202
-100
-33% -$9.72K 0.01% 258
2022
Q4
$31.3K Buy
+302
New +$31.3K 0.02% 198